Weighing risks and benefits of postchemotherapy retroperitoneal lymph node dissection: Not so easy Journal Article

  

Authors:	Bosl, G. J.; Motzer, R. J.
Article Title:	Weighing risks and benefits of postchemotherapy retroperitoneal lymph node dissection: Not so easy
Keywords:	cancer chemotherapy; treatment outcome; leukemia; cisplatin; cancer risk; risk benefit analysis; note; disease free survival; cancer staging; antineoplastic agent; lymph node dissection; lymph node excision; lymphadenectomy; metastasis; neoplasm recurrence, local; tumor volume; antineoplastic combined chemotherapy protocols; editorial; risk assessment; cancer regression; minimal residual disease; cardiovascular disease; tumor recurrence; colon cancer; testis tumor; testicular neoplasms; cancer relapse; teratoma; non seminomatous germinoma; retroperitoneum; retroperitoneal space
Journal Title:	Journal of Clinical Oncology
Volume:	28
Issue:	4
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2010-02-01
Start Page:	519
End Page:	521
Language:	English
DOI:	10.1200/jco.2009.25.0738
PUBMED:	20026799
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-77449154935&partnerID=40&md5=fce462891dd122bd95ecb578454072f9
Notes:	--- - "Cited By (since 1996): 1" - "Export Date: 20 April 2011" - "CODEN: JCOND" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/3737